Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells (Q43854610)

27 November 2017

Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells (English)

1 reference

27 November 2017

1 reference

Srinivas Venkateswarlu

1

1 reference

27 November 2017

Dawn M Dawson

2

1 reference

27 November 2017

Patricia St Clair

3

1 reference

27 November 2017

Anjana Gupta

4

1 reference

27 November 2017

James K V Willson

5

1 reference

27 November 2017

Michael G Brattain

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

21

1 reference

27 November 2017

1

1 reference

27 November 2017

78-86

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205011

27 November 2017

0 references

cites work

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Heterogeneity of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

21 January 2018

Phosphoinositide kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

How MAP kinases are regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

A synthetic inhibitor of the mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Specificity within the EGF family/ErbB receptor family signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Autocrine secretion and malignant transformation of cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

The pathway to signal achievement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

7 January 2021

The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

7 January 2021

Overexpression of p185 is not related to erbB2 amplification in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

7 January 2021

Continuous maintenance of transformed fibroblasts under reduced serum conditions: utility as a model system for investigating growth factor-specific effects in nonquiescent cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

7 January 2021

Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

7 January 2021

Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205011

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205011

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference